Trip.com (TCOM) told investors it was a leading one-stop travel platform and a go-to destination for travelers in Asia and beyond. But a federal lawsuit now alleges the company understated antitrust risk in China before a sharp stock drop.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
A federal lawsuit alleges Trip.com Group Limited understated the regulatory risk it faced in China, leaving investors exposed ahead of a significant stock decline.
A securities complaint filed in the U.S. District Court for the Eastern District of New York alleges that Trip.com Group Limited and two of its senior executives misled investors about the regulatory risks facing the company under China’s antitrust enforcement regime. The lawsuit covers purchases of Trip.com American Depositary Shares between April 30, 2024, and January 13, 2026. On January 14, 2026, following a Bloomberg report disclosing that Chinese regulators had launched a formal antitrust investigation into the company, Trip.com ADSs fell $12.90 per share, or approximately 17.05%, closing at $62.78. The stock declined a further $1.48 per ADS the following day.
If you purchased Trip.com securities during the class period and suffered losses, you may wish to explore your legal options.
Trip.com’s Business Model and Market Position
Trip.com Group Limited describes itself as a leading global one-stop travel service provider, integrating a comprehensive suite of travel products and services along with differentiated travel content. The company states that it leverages its one-stop-shop model, high-quality service, and advanced technology to expand its global reach. Trip.com is incorporated in the Cayman Islands and maintains its principal place of business in Singapore. Its American Depositary Shares trade on the NASDAQ exchange under the ticker symbol TCOM.
What the Lawsuit Alleges
The lawsuit centers on whether Trip.com and its top executives adequately disclosed the antitrust regulatory risk the company allegedly faced in China in light of its business practices and market position. The plaintiff alleges that the company’s annual reports, filed with the SEC in 2024 and 2025, used conditional language suggesting regulatory enforcement was only a future possibility, even though the risk was allegedly more immediate and concrete. The complaint contends that investors were denied material information necessary to make informed decisions about the company’s securities. Follow this case to stay informed as it develops.
What Management Said
In its 2023 Annual Report filed with the SEC on April 29, 2024, Trip.com stated that its strategy of investing in complementary businesses could be adversely affected by uncertainties in the implementation and enforcement of the PRC Anti-Monopoly Law. The filing acknowledged that the anti-monopoly enforcement authority might deem past or future transactions to have met the filing criteria under Chinese law, but framed the risk as speculative and uncertain. The company’s 2024 Annual Report, filed on April 11, 2025, contained substantially similar language, again describing potential regulatory consequences in conditional terms. Both reports carried signed certifications from CEO Jane Jie Sun and CFO Cindy Xiaofan Wang pursuant to the Sarbanes-Oxley Act.
How the Alleged Truth Emerged
On January 14, 2026, Bloomberg published an article titled “China Starts Antitrust Probe of Trip.com Ahead of Travel Peak,” reporting that China’s State Administration for Market Regulation had accused Trip.com of abusing its market position and engaging in monopolistic practices. The article noted that regulatory scrutiny of the online travel sector had been growing for months, including a meeting in August 2025 in which Guizhou’s market regulator summoned five online tourism platforms to discuss antitrust concerns, and a September 2025 instance in which the Zhengzhou market regulator summoned Trip.com for alleged violations involving restrictions on merchant transactions and prices. Following the Bloomberg report, Trip.com ADS shares dropped 17.05% on January 14, 2026, and an additional 2.35% on January 15, 2026.
Why Investors Are Paying Attention
The lawsuit argues that Trip.com’s public filings framed the risk of antitrust enforcement as a speculative future concern at a time when regulatory pressure was allegedly already escalating in measurable ways. Investors who purchased Trip.com ADSs during the class period at prices the complaint describes as artificially inflated may have incurred substantial losses when the alleged true scope of the company’s regulatory exposure became public. The case focuses on whether Trip.com’s public filings adequately described the antitrust risk it allegedly faced in China during the class period.
The Legal Framework
The complaint asserts claims under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, which prohibit materially false or misleading statements in connection with the purchase or sale of securities. It further asserts claims under Section 20(a) of the Exchange Act against CEO Jane Jie Sun and CFO Cindy Xiaofan Wang as controlling persons of the company. The plaintiff alleges that both the 2023 and 2024 annual reports contained materially misleading risk disclosures that understated the concrete and ongoing nature of antitrust enforcement risk Trip.com faced in China. If you held Trip.com securities during the class period, you may want to learn more about your rights.
About Levi & Korsinsky, LLP
Levi & Korsinsky, LLP is a nationally recognized securities litigation firm representing investors in complex shareholder actions. The firm has extensive expertise and a team of over 70 employees to serve our clients. Attorney advertising. Prior results do not guarantee similar outcomes.
Disclaimer: This article is provided for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this article. Past results do not guarantee similar outcomes.